Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Trautmann

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Biomed Research International|December 7, 2017
Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaKatharina Stock, Konrad Steinestel, Rebekka Wiesch, et al.
Oncotarget|July 27, 2018
Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsyJan Rehkämper, Konrad Steinestel, Birte Jeiler, et al.
Oncogenesis|April 23, 2022
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcomaRuth Berthold, Ilka Isfort, Cihan Erkut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid LiposarcomaLorena Heinst, Kwang Seok Lee, Ruth Berthold, et al.
The American Journal of Surgical Pathology|December 29, 2022
Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal TractAbbas Agaimy, Martina Baněčková, John De Almeida, et al.
Molecular Cancer Therapeutics|February 22, 2019
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid LiposarcomaMarcel Trautmann, Magdalene Cyra, Ilka Isfort, et al.
Oncotarget|September 24, 2016
MDM2 and CDK4 amplifications are rare events in salivary duct carcinomasInga Grünewald, Marcel Trautmann, Alina Busch, et al.
Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaMarcel Trautmann, Jasmin Menzel, Christian Bertling, et al.
British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Biomed Research International|December 7, 2017
Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaKatharina Stock, Konrad Steinestel, Rebekka Wiesch, et al.
Oncotarget|July 27, 2018
Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsyJan Rehkämper, Konrad Steinestel, Birte Jeiler, et al.
Oncogenesis|April 23, 2022
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcomaRuth Berthold, Ilka Isfort, Cihan Erkut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid LiposarcomaLorena Heinst, Kwang Seok Lee, Ruth Berthold, et al.
The American Journal of Surgical Pathology|December 29, 2022
Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal TractAbbas Agaimy, Martina Baněčková, John De Almeida, et al.
Molecular Cancer Therapeutics|February 22, 2019
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid LiposarcomaMarcel Trautmann, Magdalene Cyra, Ilka Isfort, et al.
Oncotarget|September 24, 2016
MDM2 and CDK4 amplifications are rare events in salivary duct carcinomasInga Grünewald, Marcel Trautmann, Alina Busch, et al.
Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaMarcel Trautmann, Jasmin Menzel, Christian Bertling, et al.
British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.
Pageof 5